The KCite plugin provides a means for referencing scholarly works in WordPress posts. The author includes a unique identifier for a publication in their post, and the plugin queries a web service to retrieve metadata about that publication. This metadata is then used to build a bibliography at the foot of the post, with in-place citations in the text referring to it.
The [cite] shortcode is interpreted to produce citations from the appropriate sources, also produces a formatted bibliography at the foot of the post, with appropriate links to articles.
DOI Example – [cite source=’doi’]10.1021/jf904082b[/cite]
PMID example – [cite source=’pubmed’]17237047[/cite]
Whichever ‘source’ is identified as the default (see Installation), will work without the source attribute being set in the shortcode. so:
Will be interpreted correctly as long as DOI is set as the default metadata source.
(Paragraph taken from (20375448)).
There is recognition in the pharmaceutical industry that the current paradigm of research and development needs to change. Drugs based on novel chemistry still take 10-15 years to reach the market, and development costs are usually between $500 million and $2 billion (10.1016/S0167-6296(02)00126-1) (10.1377/hlthaff.25.2.420). Most novel drug candidates fail in or before the clinic, and the costs of these failures must be borne for the companies concerned by those drug candidates that do reach the market. These costs make it difficult even for large pharmaceutical companies to bring truly new drugs to market, and are completely prohibitive for publicly-funded researchers. An alternative means of discovering new treatments is to find new uses for existing drugs or for drug candidates for which there is substantial safety data. This repositioning approach bypasses the need for many of the pre-approval tests required of completely new therapeutic compounds, since the agent has already been documented as safe for its original purpose (10.1038/nrd1468).